What is DTCX's health score?

Datacentrex, Inc. (DTCX) has a TradeApes health score of 37 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DTCX's estimated fair value?

Based on our 5-year discounted cash flow model, Datacentrex, Inc.'s estimated fair value is $1.4 per share, representing a -37.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is DTCX undervalued or overvalued?

Our model currently rates DTCX as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for DTCX... Refresh in a moment for the full analysis.

Datacentrex, Inc. (DTCX)

Technology Overvalued low weak

$2.22

Updated: 2026-06-06

TradeApes Score

Financial Strength

20 Stressed

Operating Trend

30 Weak

Relative Value

65 Healthy

Capital Allocation

30 Weak

Risk

35 Weak

Est. Fair Value $1.4

DCF Upside -37.1%

Sector Rank #2156 of 7731

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.